Spyre Therapeutics
SYRE
93.47
-4.16
-4.26%
Spyre Therapeutics
US · SYRE
#1646 by market cap
Listed 1970
93.47
-4.16
-4.26%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Quant vs Street three independent views, side by side
StockVane factor grade
B+
Momentum strategy signal
Hold
Analyst consensus
Buy
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Analyst consensus 13 analysts
Buy
Avg price target 123.38 +32.0%
Price target rangecurrent 93.47
Low115.00
Avg123.38
High135.00
Buy 100%
Hold 0%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-11-12 | J.P. Morgan | -- | Buy | 116.00 |
| 2026-11-05 | Wells Fargo | -- | Buy | 115.00 |
| 2026-11-04 | Wells Fargo | -- | Buy | 115.00 |
| 2026-11-04 | JonesTrading | -- | Buy | 130.00 |
| 2026-11-04 | BTIG | -- | Buy | 121.00 |
| 2026-11-04 | Wedbush | -- | Buy | 120.00 |
| 2026-11-04 | Stifel | -- | Buy | 131.00 |
| 2026-11-03 | Guggenheim | -- | Buy | 135.00 |
| 2026-10-21 | Citi | -- | Buy | 119.00 |
| 2026-10-20 | Citi | -- | Buy | 119.00 |
| 2026-10-19 | BTIG | -- | Buy | 121.00 |
| 2026-10-19 | Wedbush | -- | Buy | 123.00 |
| 2026-10-12 | UBS | -- | Buy | 120.00 |
| 2026-10-11 | UBS | -- | Buy | 120.00 |
| 2026-10-02 | Wells Fargo | -- | Buy | 115.00 |
| 2026-10-01 | JonesTrading | -- | Buy | 130.00 |
| 2026-10-01 | J.P. Morgan | -- | Buy | 110.00 |
| 2026-09-27 | JonesTrading | -- | Buy | 121.00 |
| 2026-09-10 | Leerink Partners | -- | Buy | 128.00 |
| 2026-09-09 | Wedbush | -- | Buy | 123.00 |
| 2026-09-09 | Jefferies | -- | Buy | 126.00 |
| 2026-09-09 | Leerink Partners | -- | Buy | 128.00 |
| 2026-09-08 | LifeSci Capital | -- | Buy | 116.00 |
| 2026-08-29 | LifeSci Capital | -- | Buy | 116.00 |
| 2026-08-26 | LifeSci Capital | -- | Buy | 116.00 |
Price target trend monthly average, last 3 years
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Spyre Therapeutics discussion 0 comments